Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,861 total articles
Exagen is a tiny diagnostics company focused on autoimmune and inflammatory disease testing. The setup is a classic small-cap biotech/diagnostics trade: limited revenue scale today, meaningful upside if adoption, reimbursement, or a commercial partnership accelerates growth, and significant downside from dilution or regulatory setbacks. This trade …
American Resources (AREC) is showing incremental operational progress and catalytic optionality through its ReElement rare-earth business. With a sub-$250M market cap, improving production metrics, and recent financing firepower, the stock is positioned for a re-rate if execution continues. Maintain Buy: enter around current levels, stop tight unde…
Red Cat is riding meaningful defense momentum: contract wins, field-trial validation and sector tailwinds are driving rapid volume and volatility. Fundamentals show a cash cushion per share but large negative free cash flow and persistent losses that make future dilution likely. This trade idea buys the current dip with a tight stop and a mid-term …
Atlassian's shares trade like a fading SaaS story while the company quietly converts AI investments into higher-value enterprise workloads and cash generation. With a $21.7B market cap, $1.20B in free cash flow and a P/S near 3.7, TEAM offers a high-conviction long with asymmetric risk/reward over the next 180 trading days.
Dollar General (DG) is mid-rerating after visible margin improvement, consistent free cash flow and a favorable footprint in price-sensitive markets. Recent Q1 results and guidance lift the fundamental base, valuation is still reasonable (EV/EBITDA ~9.1, P/E ~18), and technicals support a measured long. Entry $121, stop $110, target $140 over a lon…
Materialise (MTLS) is a profitable way to play a maturing 3D-printing specialist that is shifting mix toward higher-margin software and medical solutions. The stock trades at $6.50 with a market cap of roughly $387M and a PE of 33.6. We like a mid-term long trade targeting $8.00 with a $5.80 stop based on improving industry fundamentals, manageable…
Praxis (PRAX) is trading at roughly $315 and a market cap near $8.8B despite late-stage momentum across multiple CNS programs and an upcoming FDA decision window. I view the stock as materially undervalued versus plausible commercial outcomes and lay out a long trade with entry, stop and a two-step target plan over a 180-trading-day horizon.
Golconda Gold has started mining at Princeton Top and management is preparing a project spin-off that could materially narrow an apparent NAV discount. Technicals are constructive and short interest is elevated — set up a mid-term swing trade: enter at $1.50, target $2.20, stop $1.10. Time the trade for the next 45 trading days as spin-off news and…
Annaly offers a rare combination in the mortgage REIT space: a double-digit yield supported by rising earnings and portfolio growth. With a market cap near $16.4B, P/E around 8x and P/B roughly 1x, the stock looks attractively valued for a swing trade that collects income while waiting for spread normalization. Trade plan: enter $22.40, stop $20.50…
Tradeweb is a high-margin marketplace exposed to fixed income electronic trading and institutional flow. With $1.1B in free cash flow, durable revenue acceleration, and a conservative valuation setup, the stock can climb to $163.20 (about 65% upside) over the next 180 trading days if volumes normalize and multiple expansion follows. This trade lays…
monday.com's AI Work Platform and rising enterprise adoption could let the company move from work-management tool to a governance layer across enterprise tooling. Fundamentals remain solid (24% revenue growth, expanding enterprise customers, profitability improvements) while the stock trades at an attractive ~2.6x implied P/S on FY26 guidance. This…
Summit Therapeutics (SMMT) is a buy into the 11/14/2026 PDUFA for ivonescimab. The drug’s Phase 3 program showed an overall survival benefit versus chemotherapy and partner data have been described as impressive, giving the stock a clear binary upside if the FDA grants approval. The company’s current market cap is ~$12.1B while the fundamentals sho…
<p>Universal Music Group's core asset is intellectual property: recorded masters and publishing. That ownership creates recurring cashflow that is resilient to cycles in advertising and live performance, and today there are fresh distribution and licensing levers available to expand revenue per song. This idea lays out a long trade with defined ris…
VinFast is executing the geographic pivot I expected: factory expansion in Southeast Asia, product launches in India, and partnerships on autonomy and charging. The stock is inexpensive on a market-cap basis relative to growth optionality at $7.37B market cap, technicals show constructive momentum, and short interest remains elevated — creating asy…
Fortress Biotech (FBIO) trades at a market capitalization that looks to underappreciate its liquid assets, newly realized sale proceeds and recurring royalty streams. The stock is volatile and speculative, but the combination of a net cash-heavy balance sheet (enterprise value negative), an ongoing commercial launch and a 2.5% royalty on an FDA-app…
Centene (CNC) looks attractively valued on cash flow metrics despite membership declines. We lay out a long trade targeting $75 with a $61 stop, arguing that Medicare rate increases, cost cutting and a $7.1B FCF cushion give the company time to rebase margins and membership. The plan is for a long-term hold of roughly 180 trading days while watchin…
Cytokinetics' MYQORZO (aficamten) has cleared the hardest step - FDA approval and initial commercial launch - and early revenue and prescribing patterns suggest the drug can scale into a meaningful hypertrophic cardiomyopathy (HCM) franchise. The stock is trading at $83.26 today, reflecting high expectations. This trade idea targets label expansion…
Advanced Energy (AEIS) is benefiting from AI-led data center spending and a cyclical rebound in semiconductor equipment. Recent beats and double-digit top-line growth, combined with management guidance for strong data-center traction, support a mid-term swing trade. Entry at current levels with a disciplined stop preserves reward-to-risk against a …
Embraer looks attractive as a long trade today. A recovery in regional and business jet deliveries, steady defense demand, and an improving supply-chain backdrop give the stock asymmetric upside versus a clear downside buffer. Enter at $22.50, stop $18.00, target $30.00 over a long-term horizon (180 trading days).
Atmos Energy (ATO) combines regulated natural gas distribution scale with steady EPS and a clear dividend policy. Recent operational momentum and an attractive risk/reward near $177 make a mid-term swing trade compelling, with a target toward prior highs around $192.50 and a tight stop under $170 to protect capital.
LIME (LIME) looks like a misunderstood micro-mobility play. With improving unit economics, a cleaner balance sheet and several near-term catalysts, I expect a re-rating over the next 45 to 180 trading days. This trade idea lays out a clear entry, stop and target, plus the reasons and risks behind the call.
Generac has transformed into a key supplier for AI data centers, driving rapid multiple expansion. The business beats are tangible — commercial growth of 28% and raised guidance — but the market is already paying premium multiples (P/E ~67, EV/EBITDA ~26). This trade idea lays out a mid-term short with precise entry, stop and target, plus catalysts…
Netflix ($NFLX) has been punished recently on cautious guidance, but the company still posted record quarterly revenue, strong cash flow and high profitability. Technicals show oversold conditions while catalysts - sports rights, ad-tier expansion, gaming and analyst upgrades - can restore sentiment. We recommend buying at current levels with a mid…
PayPal remains a top-of-wallet payments franchise with multiple execution levers. This trade buys optionality on ongoing product monetization and fee recovery while keeping risk defined. Enter $70, stop $58, target $95 over a 180 trading day horizon.
IREN is a vertically integrated, renewable-powered data center operator that just crossed an implied $4 billion ARR threshold. With a market cap of roughly $17.98B and an enterprise value of $16.50B, the stock looks positioned for a meaningful re-rating if utilization and long-term contracts continue to scale. This trade idea sets a disciplined ent…
